NCT06297616: A Study of LY3841136 in Japanese Participants With Obesity or Overweight
- State
- Completed
- Phase
- Phase 1
- People
- 128 taking part
- Started
- 15 Apr 2024
- Primary completion
- 21 Nov 2025
- Arms
- Part B: Tirzepatide + LY3841136-Placebo
- Results
- None posted
- 7 Mar 2024: Trial registered
- 15 Apr 2024: Trial started
- 21 Nov 2025: Trial completed